Literature DB >> 10705945

Serum levels of coenzyme Q10 in patients with multiple sclerosis.

F de Bustos1, F J Jiménez-Jiménez, J A Molina, C Gómez-Escalonilla, C de Andrés, P del Hoyo, M Zurdo, A Tallón-Barranco, A Berbel, J Porta-Etessam, G Parrilla, J Arenas.   

Abstract

To elucidate whether serum coenzyme Q10 levels are related with the risk for multiple sclerosis (MS) or are a marker for the activity of the disease, we compared serum levels of coenzyme Q10 and the coenzyme Q10/cholesterol ratio, in 31 patients with MS (during exacerbations) and 19 matched controls using a high performance liquid chromatography technique. The mean serum coenzyme Q10 levels and the coenzyme Q10/cholesterol ratio did not differ significantly between the 2 study groups. The values did not correlate with age, age at onset, and duration of the disease. These results suggest that serum coenzyme Q10 concentrations are unrelated with the risk for MS and are not a useful marker of activity of the disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705945     DOI: 10.1034/j.1600-0404.2000.101003209.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Serum total antioxidant capacity in patients with multiple sclerosis.

Authors:  Almira Hadžović-Džuvo; Orhan Lepara; Amina Valjevac; Nesina Avdagić; Sabaheta Hasić; Emina Kiseljaković; Saida Ibragić; Azra Alajbegović
Journal:  Bosn J Basic Med Sci       Date:  2011-02       Impact factor: 3.363

Review 2.  Coenzyme Q10 effects in neurological diseases.

Authors:  H Rauchová
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

Review 3.  Coenzyme Q10 a mitochondrial restorer for various brain disorders.

Authors:  Nilima Pradhan; Charan Singh; Arti Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-10-01       Impact factor: 3.195

4.  Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.

Authors:  Maira Gironi; Bruno Borgiani; Enrica Mariani; Cristina Cursano; Laura Mendozzi; Rossella Cavarretta; Marina Saresella; Mario Clerici; Giancarlo Comi; Marco Rovaris; Roberto Furlan
Journal:  J Immunol Res       Date:  2014-03-26       Impact factor: 4.818

Review 5.  Immunology and oxidative stress in multiple sclerosis: clinical and basic approach.

Authors:  Genaro G Ortiz; Fermín P Pacheco-Moisés; Oscar K Bitzer-Quintero; Ana C Ramírez-Anguiano; Luis J Flores-Alvarado; Viridiana Ramírez-Ramírez; Miguel A Macias-Islas; Erandis D Torres-Sánchez
Journal:  Clin Dev Immunol       Date:  2013-09-24

Review 6.  Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.

Authors:  Gerwyn Morris; Michael Maes
Journal:  BMC Med       Date:  2013-09-17       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.